IL176026A0 - Medical lipolysis of fat accumulations - Google Patents

Medical lipolysis of fat accumulations

Info

Publication number
IL176026A0
IL176026A0 IL176026A IL17602606A IL176026A0 IL 176026 A0 IL176026 A0 IL 176026A0 IL 176026 A IL176026 A IL 176026A IL 17602606 A IL17602606 A IL 17602606A IL 176026 A0 IL176026 A0 IL 176026A0
Authority
IL
Israel
Prior art keywords
lipolysis
medical
fat accumulations
accumulations
fat
Prior art date
Application number
IL176026A
Original Assignee
Sanofi Aventis Deutschland
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis Deutschland filed Critical Sanofi Aventis Deutschland
Publication of IL176026A0 publication Critical patent/IL176026A0/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/28—Steroids, e.g. cholesterol, bile acids or glycyrrhetinic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/37—Digestive system
    • A61K35/413—Gall bladder; Bile
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/55—Phosphorus compounds
    • A61K8/553—Phospholipids, e.g. lecithin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/63—Steroids; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/06—Preparations for care of the skin for countering cellulitis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Birds (AREA)
  • Dermatology (AREA)
  • Nutrition Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Biotechnology (AREA)
  • Physiology (AREA)
  • Biomedical Technology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Zoology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IL176026A 2003-12-22 2006-05-30 Medical lipolysis of fat accumulations IL176026A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10361067A DE10361067A1 (en) 2003-12-22 2003-12-22 Medicinal lipolysis of fat accumulations
PCT/EP2004/014134 WO2005063169A2 (en) 2003-12-22 2004-12-11 Medical lipolysis of fat accumulations

Publications (1)

Publication Number Publication Date
IL176026A0 true IL176026A0 (en) 2006-10-05

Family

ID=34673059

Family Applications (1)

Application Number Title Priority Date Filing Date
IL176026A IL176026A0 (en) 2003-12-22 2006-05-30 Medical lipolysis of fat accumulations

Country Status (11)

Country Link
EP (1) EP1699490A2 (en)
JP (1) JP2007515439A (en)
KR (1) KR20060121238A (en)
CN (1) CN1897974A (en)
AU (1) AU2004308072A1 (en)
BR (1) BRPI0417932A (en)
CA (1) CA2551474A1 (en)
DE (1) DE10361067A1 (en)
IL (1) IL176026A0 (en)
MX (1) MXPA06006645A (en)
WO (1) WO2005063169A2 (en)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7754230B2 (en) * 2004-05-19 2010-07-13 The Regents Of The University Of California Methods and related compositions for reduction of fat
US20060127468A1 (en) 2004-05-19 2006-06-15 Kolodney Michael S Methods and related compositions for reduction of fat and skin tightening
ES2660172T3 (en) 2004-05-19 2018-03-21 Los Angeles Biomedical Research Institute At Harbor-Ucla Medical Center Injectable composition comprising sodium deoxycholate
PT1845938T (en) * 2005-02-08 2019-07-11 Univ California Methods and related compositions for reduction of fat and skin tightening
DE102007015701A1 (en) 2007-03-19 2008-09-25 Maria Clementine Martin Klosterfrau Vertriebsgesellschaft Mbh New pharmaceutical compositions for lipolysis and process for their preparation
FR2937554B1 (en) * 2008-10-27 2010-11-12 Yves Crassas AQUEOUS SALT SOLUTIONS FOR THE DESTRUCTION OF FAT FABRICS
CN102341109A (en) * 2009-03-02 2012-02-01 多丽丝·赫克斯塞尔 Medicinal cosmetic lipoatrophy
US8101593B2 (en) 2009-03-03 2012-01-24 Kythera Biopharmaceuticals, Inc. Formulations of deoxycholic acid and salts thereof
EP2471539B1 (en) 2009-08-25 2017-05-03 Medrx Co., Ltd. Transdermal composition of phosphatidylcholine and method for producing same
DE102010028365A1 (en) 2010-04-29 2011-11-03 Lichtblick Gmbh Use of a phospholipid-containing composition for the removal of subcutaneous fat accumulations
MX363465B (en) 2011-02-18 2019-03-25 Kythera Biopharmaceuticals Inc Treatment of submental fat.
US8653058B2 (en) 2011-04-05 2014-02-18 Kythera Biopharmaceuticals, Inc. Compositions comprising deoxycholic acid and salts thereof suitable for use in treating fat deposits
IN2014CN02188A (en) * 2011-08-23 2015-05-29 Kythera Biopharmaceuticals Inc
EP3119400B1 (en) * 2014-03-21 2021-06-02 Société des Produits Nestlé S.A. Maternal vitamin b2 administration for the prevention of increased adiposity, overweight or obesity in the offspring
MX2019002289A (en) * 2017-04-21 2019-09-26 Ami Pharm Co Ltd Injectable composition for topical fat reduction without pain, edema, and side effects, and method for preparing same.
KR102093872B1 (en) * 2017-07-03 2020-03-27 진호성 Injection Composition For Fat Reduction and method of manufacturing the same
JP6356329B2 (en) * 2017-09-27 2018-07-11 キテラ バイオファーマシューティカルズ，インコーポレイテッド Formulation of deoxycholic acid and its salts
KR101865562B1 (en) * 2017-11-03 2018-06-08 주식회사 펜믹스 Lipolytic composition containing phosphocholine derivatives
KR20190095833A (en) * 2018-02-07 2019-08-16 이기택 Phosphatidylcholine-free injectable composition for localized fat reduction without pain and side effect
CN110302082A (en) * 2018-03-27 2019-10-08 上海同柏生物科技有限公司 For reducing the technology and composite preparation and application that body fat deposits
CN109674696A (en) * 2018-03-27 2019-04-26 上海同柏生物科技有限公司 One kind is for stomach fat degradation technique and its preparation and application
AU2021283320A1 (en) 2020-06-01 2022-12-08 Cosmed Pharmaceutical Co., Ltd. Beauty microneedle array
JP2022020578A (en) * 2020-07-20 2022-02-01 コスメディ製薬株式会社 Cosmetic external preparation and cosmetic
KR102513115B1 (en) * 2020-12-18 2023-03-22 주식회사 레시텍 Composition for localized fat reduction comprising lithocholic acid

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10349979B4 (en) * 2003-10-24 2006-05-18 Sanofi-Aventis Deutschland Gmbh Drug targeted local lipolysis

Also Published As

Publication number Publication date
DE10361067A1 (en) 2005-07-14
WO2005063169A2 (en) 2005-07-14
CN1897974A (en) 2007-01-17
CA2551474A1 (en) 2005-07-14
MXPA06006645A (en) 2006-08-31
EP1699490A2 (en) 2006-09-13
AU2004308072A1 (en) 2005-07-14
BRPI0417932A (en) 2007-04-17
KR20060121238A (en) 2006-11-28
JP2007515439A (en) 2007-06-14
WO2005063169A3 (en) 2006-05-04

Similar Documents

Publication Publication Date Title
IL176026A0 (en) Medical lipolysis of fat accumulations
GB0520687D0 (en) Skin treatment formulations
EG24420A (en) Treatment of ophthalmic conditions
EP1737453A4 (en) Methods of using and compositions comprising immunomodulatory compounds for the treatment and management of skin diseases or disorders
DE60322451D1 (en) 4-tetrazolyl-4-phenylpiperidine derivatives for the treatment of pain
IL178827A0 (en) Use of reboxetine for the treatment of pain
GB0305150D0 (en) Use of therapeutic compounds
GB0320238D0 (en) Treatment of disease
IL175412A0 (en) Use of specific histones for the treatment of parasitic diseases
EP1675547A4 (en) Glucocerebroside treatment of disease
MY154346A (en) Dry fractionation of fat
DE602004015552D1 (en) Body Fat Monitor
EP1653982A4 (en) Treatment of malodour
IL174595A0 (en) Glucocerebroside treatment of disease
GB0330049D0 (en) The treatment of neuropathic pain conditions
GB0300428D0 (en) Medical treatment
IL172528A0 (en) Surface treatment of sars-infected lungs
IL172061A0 (en) Further therapeutic use of zolpidem
GB2409655B (en) Treatment of fluids
GB0327975D0 (en) Methods of treatment
GB0325957D0 (en) The treatment of pain
HU0302933D0 (en) Treatment of diseases
GB0322014D0 (en) The treatment of pain
GB0418556D0 (en) The treatment of pain
GB0415267D0 (en) The treatment of pain